1. Satisfaction and acceptability of cabotegravir long-acting injectable suspension for prevention of HIV: Patient perspectives from the ECLAIR trial. Issue 4 (4th July 2018) Authors: Murray, Miranda I.; Markowitz, Martin; Frank, Ian; Grant, Robert M.; Mayer, Kenneth H.; Hudson, Krischan J.; Stancil, Britt S.; Ford, Susan L.; Patel, Parul; Rinehart, Alex R.; Spreen, William R.; Margolis, David A. Journal: HIV clinical trials Issue: Volume 19:Issue 4(2018) Page Start: 129 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Chronic Hepatitis C Virus Infection and the Proinflammatory Effects of Injection Drug Use. (11th August 2016) Authors: Markowitz, Martin; Deren, Sherry; Cleland, Charles; La Mar, Melissa; Silva, Evelyn; Batista, Pedro; St. Bernard, Leslie; Gettie, Natanya; Rodriguez, Kristina; Evering, Teresa H.; Lee, Haekyung; Mehandru, Saurabh Journal: Journal of infectious diseases Issue: Volume 214:Number 9(2016:Nov. 01) Page Start: 1376 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Islatravir for the treatment and prevention of infection with the human immunodeficiency virus type 1. Issue 1 (January 2020) Authors: Markowitz, Martin; Grobler, Jay A. Journal: Current opinion in HIV & AIDS Issue: Volume 15:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Introduction: long-acting antiretrovirals for the treatment and prevention of HIV-1 infection. Issue 1 (January 2020) Authors: Markowitz, Martin Journal: Current opinion in HIV & AIDS Issue: Volume 15:Issue 1(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. 4′-Ethynyl-2-fluoro-2′-deoxyadenosine, MK-8591: a novel HIV-1 reverse transcriptase translocation inhibitor. Issue 4 (July 2018) Authors: Markowitz, Martin; Sarafianos, Stefan G. Journal: Current opinion in HIV & AIDS Issue: Volume 13:Issue 4(2018:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long-term safety and efficacy of emtricitabine and tenofovir alafenamide vs emtricitabine and tenofovir disoproxil fumarate for HIV-1 pre-exposure prophylaxis: week 96 results from a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 7 (July 2021) Authors: Ogbuagu, Onyema; Ruane, Peter J; Podzamczer, Daniel; Salazar, Laura C; Henry, Keith; Asmuth, David M; Wohl, David; Gilson, Richard; Shao, Yongwu; Ebrahimi, Ramin; Cox, Stephanie; Kintu, Alexander; Carter, Christoph; Das, Moupali; Baeten, Jared M; Brainard, Diana M; Whitlock, Gary; Brunetta, Jason... Journal: Lancet Issue: Volume 8:Issue 7(2021) Page Start: e397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Rates of non-confounded HIV-associated neurocognitive disorders in men initiating combination antiretroviral therapy during primary infection. (January 2016) Authors: Evering, Teresa H.; Applebaum, Allison; La Mar, Melissa; Garmon, Donald; Dorfman, David; Markowitz, Martin Journal: AIDS Issue: Volume 30:Number 2(2016) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Once-Weekly Oral Dosing of MK-8591 Protects Male Rhesus Macaques From Intrarectal Challenge With SHIV109CP3. (8th June 2019) Authors: Markowitz, Martin; Gettie, Agegnehu; St. Bernard, Leslie; Andrews, Chasity D; Mohri, Hiroshi; Horowitz, Amir; Grasperge, Brooke F; Blanchard, James L; Niu, Tao; Sun, Li; Fillgrove, Kerry; Hazuda, Daria J; Grobler, Jay A Journal: Journal of infectious diseases Issue: Volume 221:Number 9(2020) Page Start: 1398 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Extending access with long-acting antiretroviral therapy: the next advance in HIV-1 therapeutics and prevention. Issue 4 (July 2015) Authors: Markowitz, Martin; Meyers, Kathrine Journal: Current opinion in HIV & AIDS Issue: Volume 10:Issue 4(2015:Jul.) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. GSK1265744 Demonstrates Robust In Vitro Activity Against Various Clades of HIV-1. (1st March 2015) Authors: Karmon, Sharon L.; Mohri, Hiroshi; Spreen, William; Markowitz, Martin Journal: Journal of acquired immune deficiency syndromes Issue: Volume 68:Number 3(2015) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗